2003 - Member of the National Academy of Medicine (NAM)
His scientific interests lie mostly in Psychiatry, Internal medicine, Depression, Major depressive disorder and Endocrinology. His studies link Clinical psychology with Psychiatry. His work investigates the relationship between Internal medicine and topics such as Placebo that intersect with problems in Anesthesia.
His Depression study deals with Psychosis intersecting with Schizophrenia and Bipolar disorder. Alan F. Schatzberg works mostly in the field of Major depressive disorder, limiting it down to topics relating to Nefazodone and, in certain cases, Cognitive behavioral therapy, Psychotherapist and Cognitive therapy. His Hydrocortisone research integrates issues from Central nervous system, Neuroscience and Adrenocorticotropic hormone.
Psychiatry, Internal medicine, Depression, Endocrinology and Clinical psychology are his primary areas of study. His Psychiatry and Major depressive disorder, Antidepressant, Bipolar disorder, Anxiety and Sertraline investigations all form part of his Psychiatry research activities. His research integrates issues of Schizophrenia and Mood disorders in his study of Bipolar disorder.
His Internal medicine research focuses on Placebo and how it connects with Anesthesia. His Depression study incorporates themes from Psychotherapist and Psychosis. He regularly links together related areas like Platelet in his Endocrinology studies.
Alan F. Schatzberg focuses on Depression, Psychiatry, Major depressive disorder, Internal medicine and Clinical psychology. The study incorporates disciplines such as Neuromodulation, Functional magnetic resonance imaging, Prefrontal cortex and Transcranial magnetic stimulation in addition to Depression. His Disease research extends to the thematically linked field of Psychiatry.
His Major depressive disorder research includes elements of Escitalopram, Dorsolateral prefrontal cortex, Human brain and Sertraline. His study explores the link between Internal medicine and topics such as Antidepressant that cross with problems in Ketamine. His studies in Clinical psychology integrate themes in fields like Randomized controlled trial and Cognition.
Alan F. Schatzberg mainly investigates Major depressive disorder, Psychiatry, Depression, Internal medicine and Clinical psychology. His Major depressive disorder study integrates concerns from other disciplines, such as Bipolar disorder, Schizophrenia, Randomized controlled trial and Human brain. Alan F. Schatzberg combines subjects such as Off-label use and Disease with his study of Psychiatry.
He has included themes like Ketamine, Left superior frontal gyrus, Functional magnetic resonance imaging and Genotype in his Depression study. His work focuses on many connections between Internal medicine and other disciplines, such as Mifepristone, that overlap with his field of interest in Psychotic depression and Glucocorticoid receptor. His study looks at the intersection of Clinical psychology and topics like Cognition with Psychosis, Clinical trial and Neuroplasticity.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Dissociable Intrinsic Connectivity Networks for Salience Processing and Executive Control
William W. Seeley;Vinod Menon;Alan F. Schatzberg;Jennifer Keller.
The Journal of Neuroscience (2007)
Resting-State Functional Connectivity in Major Depression: Abnormally Increased Contributions from Subgenual Cingulate Cortex and Thalamus
Michael D. Greicius;Benjamin H. Flores;Vinod Menon;Gary H. Glover.
Biological Psychiatry (2007)
A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression.
Martin B. Keller;James P. McCullough;Daniel N. Klein;Bruce Arnow.
The New England Journal of Medicine (2000)
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs
S. Hong Lee;Stephan Ripke;Stephan Ripke;Benjamin M. Neale;Benjamin M. Neale;Stephen V. Faraone.
Nature Genetics (2013)
A Placebo-Controlled, Double-blind, Randomized Trial of an Extract of Ginkgo Biloba for Dementia
Pierre L. Le Bars;Martin M. Katz;Nancy Berman;Turan M. Itil.
Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4
Pamela Sklar;Pamela Sklar;Stephan Ripke;Stephan Ripke;Laura J. Scott;Ole A. Andreassen.
Nature Genetics (2011)
Resting-state connectivity biomarkers define neurophysiological subtypes of depression
Andrew T Drysdale;Logan Grosenick;Logan Grosenick;Jonathan Downar;Katharine Dunlop.
Nature Medicine (2017)
Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma
Charles B. Nemeroff;Christine M. Heim;Michael E. Thase;Daniel N. Klein.
Proceedings of the National Academy of Sciences of the United States of America (2003)
On the Interactions of the Hypothalamic-Pituitary-Adrenal (HPA) Axis and Sleep: Normal HPA Axis Activity and Circadian Rhythm, Exemplary Sleep Disorders
Theresa M. Buckley;Alan F. Schatzberg.
The Journal of Clinical Endocrinology and Metabolism (2005)
The American Psychiatric Publishing Textbook of Psychopharmacology
Alan F. Schatzberg;Charles B. Nemeroff.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: